These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 20448287

  • 1. Rapid reduction in tenosynovitis of the wrist and fingers evaluated by MRI in patients with rheumatoid arthritis after treatment with etanercept.
    Lisbona MP, Maymó J, Perich J, Almirall M, Carbonell J.
    Ann Rheum Dis; 2010 Jun; 69(6):1117-22. PubMed ID: 20448287
    [Abstract] [Full Text] [Related]

  • 2. Etanercept reduces synovitis as measured by magnetic resonance imaging in patients with active rheumatoid arthritis after only 6 weeks.
    Lisbona MP, Maymo J, Perich J, Almirall M, Pérez-García C, Carbonell J.
    J Rheumatol; 2008 Mar; 35(3):394-7. PubMed ID: 18203329
    [Abstract] [Full Text] [Related]

  • 3. Clinical outcome and imaging changes after intraarticular (IA) application of etanercept or methylprednisolone in rheumatoid arthritis: magnetic resonance imaging and ultrasound-Doppler show no effect of IA injections in the wrist after 4 weeks.
    Boesen M, Boesen L, Jensen KE, Cimmino MA, Torp-Pedersen S, Terslev L, Koenig M, Danneskiold-Samsøe B, Røgind H, Bliddal H.
    J Rheumatol; 2008 Apr; 35(4):584-91. PubMed ID: 18322991
    [Abstract] [Full Text] [Related]

  • 4. May etanercept and PTH (1-34) association heal erosions in early rheumatoid arthritis? A pilot study.
    Migliore A, Massafra U, Bizzi E, Argento G, Diamanti AP, Germano V, Tormenta S, Arduini F, Iannessi F, Granatas M, Laganà B.
    Eur Rev Med Pharmacol Sci; 2012 Mar; 16(3):363-9. PubMed ID: 22530354
    [Abstract] [Full Text] [Related]

  • 5. Magnetic resonance imaging: a valuable method for the detection of synovial inflammation in rheumatoid arthritis.
    Goupille P, Roulot B, Akoka S, Avimadje AM, Garaud P, Naccache L, Le Pape A, Valat JP.
    J Rheumatol; 2001 Jan; 28(1):35-40. PubMed ID: 11196540
    [Abstract] [Full Text] [Related]

  • 6. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Keystone EC, Schiff MH, Kremer JM, Kafka S, Lovy M, DeVries T, Burge DJ.
    Arthritis Rheum; 2004 Feb; 50(2):353-63. PubMed ID: 14872476
    [Abstract] [Full Text] [Related]

  • 7. The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis.
    Anandarajah AP, Schwarz EM, Totterman S, Monu J, Feng CY, Shao T, Haas-Smith SA, Ritchlin CT.
    Ann Rheum Dis; 2008 Mar; 67(3):296-301. PubMed ID: 17967829
    [Abstract] [Full Text] [Related]

  • 8. Influence of -308 A/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritis.
    Guis S, Balandraud N, Bouvenot J, Auger I, Toussirot E, Wendling D, Mattei JP, Nogueira L, Mugnier B, Legeron P, Landt O, Serre G, Roudier J, Roudier C.
    Arthritis Rheum; 2007 Dec 15; 57(8):1426-30. PubMed ID: 18050183
    [Abstract] [Full Text] [Related]

  • 9. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
    van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ, Etanercept Study 400 Investigators.
    Ann Rheum Dis; 2008 Feb 15; 67(2):182-8. PubMed ID: 17728331
    [Abstract] [Full Text] [Related]

  • 10. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept.
    Baraliakos X, Davis J, Tsuji W, Braun J.
    Arthritis Rheum; 2005 Apr 15; 52(4):1216-23. PubMed ID: 15818694
    [Abstract] [Full Text] [Related]

  • 11. Repair of erosions in patients with rheumatoid arthritis treated with etanercept: magnetic resonance imaging findings after 1 year of follow-up.
    Lisbona M, Maymó J, Solano A, Almirall M, Navallas M, Ares J, Carbonell J.
    Scand J Rheumatol; 2013 Apr 15; 42(6):437-44. PubMed ID: 23607571
    [Abstract] [Full Text] [Related]

  • 12. Monitoring anti-TNFalpha treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage.
    Haavardsholm EA, Østergaard M, Hammer HB, Bøyesen P, Boonen A, van der Heijde D, Kvien TK.
    Ann Rheum Dis; 2009 Oct 15; 68(10):1572-9. PubMed ID: 19019893
    [Abstract] [Full Text] [Related]

  • 13. A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial.
    Axelsen MB, Eshed I, Hørslev-Petersen K, Stengaard-Pedersen K, Hetland ML, Møller J, Junker P, Pødenphant J, Schlemmer A, Ellingsen T, Ahlquist P, Lindegaard H, Linauskas A, Dam MY, Hansen I, Horn HC, Ammitzbøll CG, Jørgensen A, Krintel SB, Raun J, Krogh NS, Johansen JS, Østergaard M, OPERA study group.
    Ann Rheum Dis; 2015 May 15; 74(5):867-75. PubMed ID: 24412895
    [Abstract] [Full Text] [Related]

  • 14. [Clinical experience with TNF-alpha inhibitors in rheumatoid arthritis].
    Wallenius M, Rødevand E, Skomsvoll JF.
    Tidsskr Nor Laegeforen; 2005 Jun 16; 125(12):1664-6. PubMed ID: 15976836
    [Abstract] [Full Text] [Related]

  • 15. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA, Conaghan PG, O'Connor PJ, Karim Z, Greenstein A, Brown A, Brown C, Fraser A, Jarret S, Emery P.
    Arthritis Rheum; 2005 Jan 16; 52(1):27-35. PubMed ID: 15641102
    [Abstract] [Full Text] [Related]

  • 16. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
    Kremer JM, Weinblatt ME, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Jackson CG, Atkins KM, Feng A, Burge DJ.
    Arthritis Rheum; 2003 Jun 16; 48(6):1493-9. PubMed ID: 12794815
    [Abstract] [Full Text] [Related]

  • 17. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.
    Rudwaleit M, Baraliakos X, Listing J, Brandt J, Sieper J, Braun J.
    Ann Rheum Dis; 2005 Sep 16; 64(9):1305-10. PubMed ID: 15778243
    [Abstract] [Full Text] [Related]

  • 18. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.
    Keystone E, Freundlich B, Schiff M, Li J, Hooper M.
    J Rheumatol; 2009 Mar 16; 36(3):522-31. PubMed ID: 19228659
    [Abstract] [Full Text] [Related]

  • 19. Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data.
    Baraliakos X, Brandt J, Listing J, Haibel H, Sörensen H, Rudwaleit M, Sieper J, Braun J.
    Arthritis Rheum; 2005 Dec 15; 53(6):856-63. PubMed ID: 16342093
    [Abstract] [Full Text] [Related]

  • 20. Computerized measurement of magnetic resonance imaging erosion volumes in patients with rheumatoid arthritis: a comparison with existing magnetic resonance imaging scoring systems and standard clinical outcome measures.
    Bird P, Lassere M, Shnier R, Edmonds J.
    Arthritis Rheum; 2003 Mar 15; 48(3):614-24. PubMed ID: 12632412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.